EXTENDED Application Deadline: January 30, 2026 at 11:59pm PT
Course lectures begin Feb 3, 2026
Course Application
Anyone, anywhere can sign up to take HTGAA as a Global Student, online and free of charge! Just fill out the
Spring 2026 HTGAA Application
to be considered to join the course — applications will be evaluated on a rolling basis.
Note
Application deadline EXTENDED: January 30, 2026 at 11:59pm PT
Enrolled MIT/Harvard students can apply to take the course for credit as MAS.885 in the MIT course catalog; please be sure to
fill out the above application to be considered.
Slides/recordings: linked from each week page after class
Wednesdays, 5–6 PM ET
Room: MIT E15-359 & Zoom
Slides/recordings: linked from each week page after recitation
Global recitations are organized locally by each node (via Zoom).
Contact your Node lead for times and links.
Days & times vary based on the needs of each week’s lab
Room: 68-083
Week-specific sessions and protocols appear on each week’s Lab page.
Available upon request. Coordinate directly with the teaching team.
Grading
For registered MIT and Harvard students taking this class in person and
for credit (MIT course MAS.885), grades will be determined using the following rubric:
Component
Percentage
Lecture, Recitation, and Lab Attendance and Participation
33%
Weekly Assignments (Class Write-ups and Lab Documentation)
33%
Final Project (Group work and individual project)
34%
Committed Listeners are assessed on participation, homework, and final project presentation;
those meeting the standards are awarded a Certificate of Completion at the end of the course.
Contact your Global Node for grading details,
Course Staff
Head Instructor: Dr. David S. Kong — dkong@mit.edu
This week lays the foundation for ethics, safety, and governance in biotechnology — and we get hands-on with lab basics.
Lecture (Tues, Feb 3) The Lecture recording will be posted here when Zoom releases it.
Recitation (Wed, Feb 4) The Recitation recording and recitation slides will be posted here when Zoom releases it.
if I have [words in brackets] does it freak out?
I need words around it to see
I need words around it to see no inline
some text
words in caption words1
words in caption words2
Subsections of Weeks
Week 1 — Principles & Practices
This week lays the foundation for ethics, safety, and governance in biotechnology — and we get hands-on with lab basics.
Lecture (Tues, Feb 3)
The Lecture recording will be posted here when Zoom releases it.
Recitation (Wed, Feb 4)
The Recitation recording and recitation slides will be posted here when Zoom releases it.
Make sure to document every step of the in-silico and lab experiments. Make sketches, screenshots, notes, drawings - anything that helps you - and others understand the experiment.
Your Documentation should help you - and others - to understand the topic. Don’t be afraid to add things that don’t work. Show your failures - and how you did overcome them. Your Documentation should be a description of the amazing journey you are on!
Class Assignment
First, describe a biological engineering application or tool you want to develop and why. This could be inspired by an idea for your HTGAA class project and/or something for which you are already doing in your research, or something you are just curious about.
Next, describe one or more governance/policy goals related to ensuring that this application or tool contributes to an “ethical” future, like ensuring non-malfeasance (preventing harm). Break big goals down into two or more specific sub-goals. Below is one example framework (developed in the context of synthetic genomics) you can choose to use or adapt, or you can develop your own. The example was developed to consider policy goals of ensuring safety and security, alongside other goals, like promoting constructive uses, but you could propose other goals for example, those relating to equity or autonomy.
Next, describe at least three different potential governance “actions” by considering the four aspects below (Purpose, Design, Assumptions, Risks of Failure & “Success”). Try to outline a mix of actions (e.g. a new requirement/rule, incentive, or technical strategy) pursued by different “actors” (e.g. academic researchers, companies, federal regulators, law enforcement, etc). Draw upon your existing knowledge and a little additional digging, and feel free to use analogies to other domains (e.g. 3D printing, drones, financial systems, etc.).
Purpose: What is done now and what changes are you proposing?
Design: What is needed to make it “work”? (including the actor(s) involved - who must opt-in, fund, approve, or implement, etc)
Assumptions: What could you have wrong (incorrect assumptions, uncertainties)?
Risks of Failure & “Success”: How might this fail, including any unintended consequences of the “success” of your proposed actions?
Next, score (from 1-3 with, 1 as the best, or n/a) each of your governance actions against your rubric of policy goals. The following is one framework but feel free to make your own:
Your context:
Does the option:
Option 1
Option 2
Option 3
Enhance Biosecurity
• By preventing incidents
• By helping respond
Foster Lab Safety
• By preventing incident
• By helping respond
Protect the environment
• By preventing incidents
• By helping respond
Other considerations
• Minimizing costs and burdens to stakeholders
• Feasibility?
• Not impede research
• Promote constructive applications
Last, drawing upon this scoring, describe which governance option, or combination of options, you would prioritize, and why. Outline any trade-offs you considered as well as assumptions and uncertainties. For this, you can choose one or more relevant audiences for your recommendation, which could range from the very local (e.g. to MIT leadership or Cambridge Mayoral Office) to the national (e.g. to President Biden or the head of a Federal Agency) to the international (e.g. to the United Nations Office of the Secretary-General, or the leadership of a multinational firm or industry consortia). These could also be one of the “actor” groups in your matrix.
Weekly Assignment
Reflecting on what you learned and did in class this week, outline any ethical concerns that arose, especially any that were new to you. Then propose any governance actions you think might be appropriate to address those issues. This should be included on your class page for this week.
Final Project Assignment
As part of your final project, design one or more strategies to ensure that your project, and what it enables, contributes to growing an ethical biological future.
Synthetic Genomics: Options for Governance This is an older but useful report for thinking about a variety of options for the governance of biotechnology that inspired this week’s homework
National Security Commission on Emerging Biotechnology: This U.S. Congressional Commission will produce its first “comprehensive” report at the end of 2024 but has an “interim” 2023 report posted now, and they are currently soliciting input to guide national policy regulating biotech
iGEM 2020 Safety Hub: This page includes links to many useful resources including the WHO biosafety manual, the NIH guidelines and the CDC Biosafety in Microbial and Biomedical Laboratories Guide; additional information is available on the iGEM 2023 Responsibility page
Handbook for Community Biology Spaces: A handbook co-developed by community biolobabs, designed as a living document that can be updated and expanded by the community over time
DIYBio Ask a biosafety expert This page includes a portal where you can get your biosafety questions answered by professionals
Rooftop Solar and the Four Levers of Social Change: A blog post from Ethan Zuckerman considering different types of ways of regulating behavior, adopted in part from Lawrence Lessig’s book: Code 2.0, and explored in the context of energy consumption and production
Subsections of Week 1 (Feb 3)
Lab — Introduction to Pipetting and Dilutions
Overview
Objective
Welcome to HTGAA! This is our very first lab, and in this lab we will introduce students to the foundational techniques of pipetting and serial dilutions, critical for precise liquid handling and solution preparation in biological and chemical experiments.
This is a one-day lab with two protocols covered on mixing colors and dilution. By the end of the lab, students will confidently use pipettes, prepare solutions with desired concentrations, and troubleshoot common errors in pipetting.
Concepts Learned & Skills Gained
Students will:
Understand Units and Conversions: moles (mol), molarity (M), and conversions between µL, mL, and L.
Perform Serial Dilutions: Learn the stepwise dilution process to achieve specific solution concentrations.
Gain Pipetting Proficiency: Operate P20, P200, and P1000 pipettes accurately for volume transfers.
Visualize Mixing Outcomes: Use colors and absorbance measurements to observe concentration gradients.
Pre-Lab
Reading
Key Definitions
Here are some key definitions we’d like you to know before you get started.
Moles (mol): A unit representing $6.022 \times 10^{23}$ particles (atoms, molecules, etc.).
Molarity (M): Concentration defined as moles of solute per liter of solution (mol/L).
Conversions:
1 L = 1000 mL = 1,000,000 μL
1 M = 1000 mM = 1,000,000 μM
Planning Your Experiments
To calculate the volume of water needed for a dilution, use the formula: $$C_1 V_1 = C_2 V_2$$
$C_2$ : Final concentration (desired concentration).
$V_2$ : Final volume (total volume of the diluted solution).
Steps:
Rearrange the formula to calculate $V_1$: $$ V_1 = \frac{C_2 V_2}{C_1} $$
Calculate the volume of water (let’s call it $V_Water$) to add: $$ V_Water = V_2 - V_1 $$
Practice
Dilution Practice 1
Scenario: The stock concentration of a mystery substance (MS) is 5 M. Calculate how to dilute to 100 µM (0.1 mM):
Use sequential 1:499 and 1:99 dilution steps for accurate preparation.
Step 1: Dilute 5 M (5,000,000 µM) to 10,000 µM (500x dilution).
Step 2: Dilute 10,000 µM to 100 µM (100x dilution).
Dilution Practice 2
The stock concentration of a mystery substance (MS) is 5 M.
If the molar mass of MS is 532 g/mol, what’s the concentration of the stock concentration in g/mL? To make your life easier, you can use one of many online calculators.
You will perform a serial dilution to get 100 uM of MS. Devise a plan to dilute a 5 M MS solution to 100 uM. How many dilution steps will we need? Which tubes should we use? Which pipettes?
Fill out the following chart to prepare a final reaction with 60 uL reaction volume. Why did we make 100 uM MS if we actually need 40 uM MS? Why not prepare 40 uM in serial dilutions?
Reagent
Stock concentration
Desired concentration
Volume
Loading dye
6X
1X
MS
100 uM
40 uM
dH2O
n/a
n/a
Note
Please fill this out before coming to lab.
Additional resources
You must watch or be able to understand the following videos:
Mysterious substance (food coloring with water), henceforth: MS
Red, Blue and Yellow food coloring solutions
Gel loading dye (commonly used reagents for loading gels, strong purple color)
Part 1: Mixing Color
Prepare tubes with red, yellow, and blue food coloring solutions OR watercolor
Take ten tubes and mark them with numbers 1 to 6
Tube 1, 2 and 3: add 500 uL each red, yellow, and blue solution to the tube.
Tube 4: add 220 uL red solution to the tube, and add 220 uL yellow solution.
Try adding this in 2 steps: add 200 uL first, and then 20 uL. Discard your tips after you add one color!
Tube 5: add 525 uL yellow solution to the tube, and add 525 uL blue solution.
Tube 6: add 155 uL red solution to the tube, and add 155 uL blue solution.
Now you have a rainbow! You can try mixing other colors with the solutions.
Try plating different volumes (e.g. 1uL, 2uL, 5uL, 10uL) on a petri plate to make some designs and build your intuitive understanding of these volumes.
Part 2: Performing Serial Dilution
Perform serial dilutions to get 100 uM (0.1 mM) of MS.
Every time you mix in liquid, pipette up and down three or four times to ensure the two liquids are mixed thoroughly.
Mark each tube with its respective concentration using a pen.
Prepare a final reaction of 60 uL based on your table in the pre-lab.
Bonus: Take 20 uL from the final reaction and pipette it to a pre-prepared gel well. Wells are a bit trickier because they are thin and your pipette tip will puncture the gel if you’re not careful. Be gentle!
Lysis protein DNA sequence
```
atggaaacccgattccctcagcaatcgcagcaaactccggcatctactaatagacgccggccattcaaacatgaggattacccatgtcgaagacaacaaagaagttcaactctttatgtattgatcttcctcgcgatctttctctcgaaatttaccaatcaattgcttctgtcgctactggaagcggtgatccgcacagtgacgactttacagcaattgcttacttaa
```
stop
Lysis protein DNA sequence `atggaaacccgattccctcagcaatcgcagcaaactccggcatctactaatagacgccggccattcaaacatgaggattacccatgtcgaagacaacaaagaagttcaactctttatgtattgatcttcctcgcgatctttctctcgaaatttaccaatcaattgcttctgtcgctactggaagcggtgatccgcacagtgacgactttacagcaattgcttacttaa`
stop
Lysis protein DNA sequence atggaaacccgattccctcagcaatcgcagcaaactccggcatctactaatagacgccggccattcaaacatgaggattacccatgtcgaagacaacaaagaagttcaactctttatgtattgatcttcctcgcgatctttctctcgaaatttaccaatcaattgcttctgtcgctactggaagcggtgatccgcacagtgacgactttacagcaattgcttacttaa
stop
Lysis protein DNA sequence with Codon-Optimization
`ATGGAAACCCGCTTTCCGCAGCAGAGCCAGCAGACCCCGGCGAGCACCAACCGCCGCCGCCCGTTCAAACATGAAGATTATCCGTGCCGTCGTCAGCAGCGCAGCAGCACCCTGTATGTGCTGATTTTTCTGGCGATTTTTCTGAGCAAATTCACCAACCAGCTGCTGCTGAGCCTGCTGGAAGCGGTGATTCGCACAGTGACGACCCTGCAGCAGCTGCTGACCTAA`
Lysis protein DNA sequence with Codon-Optimization ATGGAAACCCGCTTTCCGCAGCAGAGCCAGCAGACCCCGGCGAGCACCAACCGCCGCCGCCCGTTCAAACATGAAGATTATCCGTGCCGTCGTCAGCAGCGCAGCAGCACCCTGTATGTGCTGATTTTTCTGGCGATTTTTCTGAGCAAATTCACCAACCAGCTGCTGCTGAGCCTGCTGGAAGCGGTGATTCGCACAGTGACGACCCTGCAGCAGCTGCTGACCTAA
stop
Lysis protein DNA sequence with Codon-Optimization
Throughout the term each student defines and executes an Individual Final Project and then presents their work
before the class as a culmination of their semester. This applies to all students including local for-credit MIT/Harvard
students as well as the Global “Committed Listeners” who present their projects on Zoom to the Course Instructors, Lecturers and
Teaching Staff (note that this presentation is one of the requirements for Committed Listeners to earn a Certificate of
Completion for the course).
Info
May 12, 2026: MIT / Harvard Individual Final Project Presentations (~3 Hours)
May 13, 2026: Global Committed Listener Individual Final Project Presentations (~9-12 Hours)
In addition, all students have the opportunity to contribute to the Group Final Project, a collaborative effort
towards a significant research result which runs through the term and sometimes beyond.
Project brief & stages — 2025 continues from 2024’s effort
Subsections of Final Projects
Individual Final Project
For your Individual Final Project, write up your project and results on your HTGAA webpage following the guidelines below.
You will present your project from that online writeup; presentations should be 6 minutes for MIT/Harvard students and 3 minutes
for Global Committed Listeners, with 1-2 minutes of questions and discussion following.
Important Dates
Feb 25, 2026: Share 3 Individual Final Project ideas (1 slide each, in Google slide deck to be provided) Mar 18, 2026: Finalize Individual Final Project topic; send TAs Twist designs Apr 30 & May 1, 2026: Final project open Lab sessionn #1 (MIT/Harvard) May 7 & 8, 2026: Final project open Lab sessionn #2 (MIT/Harvard) May 12, 2026: MIT / Harvard Individual Final Project presentations (~3 Hours) May 13, 2026: Global Committed Listener Individual Final Project presentations (~9-12 Hours)
Links:
Links will be available later in the semester:
(Signup sheets for a presentation slot)
(A schedule of MIT/Harvard TA availability for lab work)
(Signup sheet for MIT/Harvard Lab slots)
SECTION 1: ABSTRACT
1. Provide an abstract/summary for your project. (minimum 150 words)
Self-contained description of the project
Should contain a brief outline of:
Significance
Broad objectives
Hypotheses
Specific aims
Methods to be employed
Use lay language (i.e., understandable by the general public) as much as possible
SECTION 2: BACKGROUND
Provide background information and research for your final project. This should describe the current state of knowledge related to your project and should include a critical evaluation of the literature that identifies the gap in knowledge that this project will fill. Explain the larger context of your project area. What are the challenges and obstacles related to your project? What problem(s) are you seeking to address?
Cite at least 2 peer-reviewed research papers. Include any figures or visuals to help assist in explaining the background of your project area.
(min. 2 paragraphs)
SECTION 3: VISION and IMPACT
3a. Introduce the vision and impact of your final project. (min. 1-2 paragraphs) What is the overall vision and goal of your project? How will the world be different if your project is successful? Include figures and visuals as appropriate.
Examples of topics to discuss
How your project solves a pressing problem in the world
Importance of the problem it solves or the critical barrier(s) to progress in the field that the proposed project addresses
The ways in which it contributes to the larger society
How the proposed project will improve scientific knowledge, technical capability, and/or clinical practice in one or more broad fields
How the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field will be changed if the proposed aims are achieved
3b. Describe how your project is innovative (min. 3 sentences)
Examples of topics to discuss
Novel applications, usage, or development of theoretical concepts, approaches, methodologies, instrumentation, and/or interventions
How it challenges current theories, paradigms, or ways in which technology/biological tools are used
How your project pushes the boundaries of synthetic biology
3c. Describe the bioethical considerations involved in your project. (min. 2 paragraphs)
First paragraph: Include what ethical implications are involved in your project. Try to suggest ethical the principle(s) you may apply (e.g. non-maleficence, justice)?
Second paragraph: Describe the measures that should be taken to ensure that your project is ethical (both in how the research is conducted and in its broader implications for society). You may wish to answer the following questions:
What action(s) do you propose?
What are potential unintended consequences of your proposed actions?
What could you have wrong (e.g., incorrect assumptions and uncertainties)?
What are alternatives to your proposed actions?
SECTION 4: PROJECT AIMS
Outline three aims of your final project (min. 3 sentences, at least one for each aim)
The first aim should be structured “The first aim of my final project is to [insert an achievable experimental goal that encompasses your project] by utilizing [insert protocols/tools/strategies you will use to achieve your goal]”
State or link any methods/experimental protocols/OpenTrons protocols/DNA or protein designs/protein design tools or models/Twist orders you will use
You will provide a detailed, step-by-step outline of how you will achieve your goal for the first aim in the experimental design portion of this assignment (i.e., in question 7)
Feel free to run your goal by a TA
The second aim should be a medium-term aim that is a follow-up to your first aim and focused on goals beyond this class, building toward your third, visionary aim
For example, your second aim may be to successfully execute a set of experimental protocols, solve a specific problem, or develop a specific technology building upon the goals of your first aim.
The third aim should be a visionary, long-term aim
Reveal how the larger goal of the project can be impactful
Examples: challenging an existing paradigm or clinical practice, addressing a critical barrier to progress in the field, describing how you envision a new technology to change how a certain type of research is conducted
SECTION 5: EXPERIMENTAL DESIGN
Share a detailed experimental plan for your final project. Include a timeline for each part of your experimental plan (i.e., how long you would expect each step in your final project to take). (min. 15 lines/sentences—a numbered list is acceptable)
Include specific methods/tools/technologies/biological concepts for each part of the final project and analysis
Include any details related to any DNA designs and explain your design choices
This section will be used to determine whether the experiments are well designed, feasible, and likely to succeed in testing your hypothesis
Often this section is broken into discrete tasks/sub-aims
For each experiment and/or analysis, include a description of your expected results
If possible, include figure(s) that visually shows a broad workflow of your project or a specific aspect of your experimental plan
SECTION 6: RESULTS
Share the experimental results of your project. Include figures, tables, graphs, etc. to represent your experimental work. What did you measure and what were the results of those measurements? These results can be from lab work, computational methods, etc.
Here is a non-exhaustive list of areas where you can provide results:
Performing a PCR reaction using primers relevant to your final project
Performing a Gibson assembly relevant to your final project
Designing DNA relevant to your final project
Creating and performing a cell-free assay related to your final project
Creating and running a code to validate an aspect of your final project
Developing a model or completing a computational analysis relevant to your project
Designing DNA construct(s) that can express at least one gene of interest, ordering it (via Twist), and testing of the expression of the construct(s) (potentially using an OpenTrons robot)
In the event you were unable to run certain experiments, please share your expected results. What kind of data were you hoping to get and why? Show an example data set or plot for reference (this could be from the literature or something you draw or plot).
SECTION 7: DISCUSSION AND FUTURE WORK
7a. Discussion (2 paragraphs minimum). Interpret your results. What worked? What didn’t? What data met your expectations? What did not go as planned and why do you think it didn’t work?
Discuss any other aspects of your project here as well. What were foreseen and/or unforeseen challenges? What strategies did you employ, or will you employ, to overcome these challenges?
7b. Future Work (1 paragraph minimum).
What are the next immediate steps you would like to take? What is your short term future work? What is your medium and long term future work? How do these plans relate to your aims?
SECTION 8: TECHNIQUES, TOOLS, AND TECHNOLOGY
8. We discussed and practiced various techniques related to synthetic biology throughout the semester. Place a check next to the techniques relevant to your project.
Chassis Selection (e.g., DH5α, Bl21-DE3 for expression)
Registry of Standard Biological Parts
FreeGenes
Plasmid Preparation
Bacterial Culturing
Quality Control / Analysis
Bacterial Processing (e.g., Centrifugation, Lysis, DNA Purification)
Cell-Free System
Cell-Free Reactions
Freeze-Dried Cell-Free Systems
NEB Express Kits
miniPCR Tools
Gibson Assembly
Primer Design or Selection
PCR Reactions
Gibson Assembly
Other Cloning Methods (e.g., Restriction Enzyme Digestion or Gateway Cloning)
Creating Twist Order
9. Expand upon two techniques you checked in the previous question by describing how you would utilize those techniques in your final project. (min. 4 sentences
SECTION 9: ADDITIONAL INFORMATION
10a. List all references cited in this assignment (bullet-point list)
10b. Create a supply list and budget for your project (bullet-point list)
What supplies, equipment, and budget is needed for your project to work?
Phage therapy is the therapeutic use of bacteriophages to treat bacterial infections. Bacteriophages, or phages, are viruses that infect bacteria. They are highly specific, often infecting only a single strain of bacteria. Because of this specificity, phage therapy has potential advantages over traditional antibiotic treatment, which can kill beneficial bacteria along with the harmful ones. Phage therapy is seen as a solution to the problem of antibiotic resistance, which is becoming prevalent worldwide. At the current trend, in 26 years, the number of deaths attributed to antibiotic resistance are projected to become comparable with the number of deaths caused by cancer.
This project represents our HTGAA large-scale group research effort, where every participant has the opportunity to contribute to state-of-the-art research using advanced techniques. The potential impact of this work is significant, with the potential to make a real difference in people’s lives. For instance, consider the Patterson story, which highlights the transformative power of phage therapy. This Group Final Project is not just about academic advancement, but about making a tangible difference in the global fight against antibiotic resistance.
As evidenced in the Patterson story, a significant challenge in phage therapy is the ability of bacteria to rapidly develop resistance to the phages. In Patterson’s case, the initial phage cocktail became ineffective after a few days. Consequently, another cocktail was developed and administered. Once again, it became ineffective after a short period. It was not until the third cocktail was introduced that the patient was finally cured. This highlights the need for continual monitoring and adaptation in phage therapy, reflecting the dynamic nature of bacterial resistance.
You can find a detailed introduction into bacteria, phages and phage therapy in our HTGAA Bootcamp Part 1
The Group Final Project
Despite the great advantages of phage therapy over conventional antibiotics, bacteriophages have a major limitation: Bacteria can develop ways to defend themselves against the phages and become resistant. But, in contrast to the static nature of antibiotics, phages have the power to evolve too. For billions of years, there has been an arms race between phages and bacteria. But now, with the development of new tools in synthetic biology such as protein engineering and the synthesis of new genomes harboring advantageous mutations, we can try to give the phages a head start. We attempt this by engineering their DNA or RNA, so they are prepared in case they encounter bacteria developing a resistance. This is the overall goal of the group final project. Specifically, we want to engineer the bacteriophage MS2 to be more prepared and more efficient in killing its host bacteria Escherichia coli (E. coli).
MS2 bacteriophage
MS2 bacteriophages infect E. coli bacteria with a high specificity. It is a very small virus consisting of coat proteins, a maturation protein and genetic material. They infect bacteria by attaching to the F-pilin protein on the host cell membrane and entering the cell. Once inside, the viral RNA acts as a messenger for phage protein production. All proteins for virion assembly are translated and the virus RNA is replicated. Next, new viruses form by assembling the coat and maturation proteins and encapsulating the virus RNA. Finally, a lysis protein expressed from the viral RNA triggers bacterial lysis by causing cell wall breakdown, whereby the new phages are released into the environment to infect new bacteria.
Empowering MS2 in their fight against E. coli
To make phages stronger against their host and to prepare them against host resistance, we can introduce mutations into their genes to slightly change the structure and/or function of the encoded proteins. Four genes are present on the MS2 RNA: 1. the maturation protein (A), 2. the coat protein (coat), 3. the lysis protein (L) and 4. the replicase (rep). For this course, we focus on the L gene encoding the lysis protein.
The exact function of the L protein is unknown, however, it is thought to form oligomers that can then integrate into the cell membrane to form pores, which ultimately lyse and kill the bacterial cell. This lysis protein is crucial for the phage to complete its life cycle and release new phages to infect more bacteria. Because of its importance, E. coli can try to intervene in the lysis protein production to stop the spread of the phages. For the translation and processing of the viral proteins, the phage heavily relies on the bacterial protein machinery. One example for such a protein is DnaJ, a chaperone responsible for proper protein folding, which has been shown to be important for MS2 lysis protein processing. E. coli can mutate this chaperone, preventing the lysis protein from interacting with DnaJ. This in turn causes the lysis protein to lose its function and stops MS2 from infecting more bacteria.
In this project, we want to engineer the lysis protein to increase the ability of MS2 to overcome potential E. coli resistance. We can attempt this by mutating the lysis protein to change its properties. Together, we aim for finding mutations that change the lysis protein one of the following ways: (1) an independence of lysis protein processing from DnaJ or other bacterial chaperones and (2) a faster or more efficient killing of E. coli to reduce the window in which the host can acquire resistance. In the course of this class, we will proceed through the following stages to create and test new MS2 phage mutants:
Stage 2: Synthesize the L protein mutant gene via Twist
Stage 3: Clone the L protein mutant gene into a plasmid using Gibson Assembly
Stage 4: Test the L protein mutant’s structural integrity using the Nuclera system
Stage 5: Test the L protein in E. coli (details will follow)
With this group project, each student will have the opportunity to actively contribute to authentic scientific research that will advance scientific knowledge and could potentially have an impact on people’s lives.